CD36 and peripheral arterial disease: Effect of CD36-blocking on tissue factor-triggered thrombin generation in platelet-rich plasma from 10 patients with the peripheral arterial disease (PAD) over time treated with aspirin (ASA) in the absence or presence of clopidogrel or low-dose rivaroxaban.